Researchers from Carnegie Mellon University, the University of Pennsylvania, and the University of Pittsburgh have developed lipid nanoparticles that are designed to carry mRNA specifically to the pancreas. The researchers packaged mRNA instructions for a bioluminescent protein into lipid nanoparticles and then injected them into mice either intravenously or intraperitoneally (that is, directly into the fluid that surrounds the pancreas). Using the glowing protein to see where the mRNA had traveled, they found that intraperitoneal injection resulted in more abundant and more specific delivery to the pancreas, compared with intravenous injection.
An official website of the United States government.